What rocuronium dose should be used for rapid sequence intubation, including adjustments for children and patients with hepatic impairment, elderly, or frail conditions?

Rocuronium Dose for Rapid Sequence Intubation

For RSI in adults, administer rocuronium 1.0-1.2 mg/kg IV to achieve optimal intubating conditions within 60 seconds, comparable to succinylcholine. 1

Standard Adult Dosing

The evidence strongly supports higher doses for RSI than traditional intubation:

• RSI dose: 1.0-1.2 mg/kg IV provides excellent-to-good intubating conditions in <2 minutes 1, 2
• Standard intubation dose: 0.6 mg/kg IV achieves adequate conditions but requires ~2 minutes and may be insufficient for true RSI 3, 4
• Lower dose (0.45 mg/kg) is inadequate for RSI and should be avoided in emergency situations 4

Recent evidence demonstrates that doses >1.2 mg/kg significantly improve first-pass intubation success (100% vs 89.5%) compared to doses ≤1.2 mg/kg, with fewer total attempts required 5. This supports the upper end of the dosing range for critical situations.

Key Timing Considerations

• Maximum blockade occurs within 3 minutes at standard doses 3
• Duration of action: 30-60 minutes (significantly longer than succinylcholine's 5-10 minutes) 3, 2
• Sugammadex should be immediately available when using rocuronium for RSI 1

Pediatric Dosing

In children, the recommended RSI dose is 1.0-1.2 mg/kg IV, NOT the standard 0.6 mg/kg dose. 1

Age-Specific Considerations

• Standard pediatric intubation dose: 0.6 mg/kg 4
• RSI in children: Use higher doses (1.0-1.2 mg/kg) when rapid intubation is required 1
• The 0.6 mg/kg dose is insufficient for clinically acceptable conditions in 100% of children at 60 seconds 6

Important caveat: Rocuronium is NOT recommended for RSI in pediatric patients per FDA labeling 4. However, guidelines support its use at doses >0.9 mg/kg when succinylcholine is contraindicated 1. The pediatric evidence shows comparable intubating conditions between succinylcholine 1.5 mg/kg and rocuronium 1.2 mg/kg at 60 seconds 1.

Pediatric Maintenance Dosing

• 0.15 mg/kg at reappearance of T3 (third twitch of train-of-four) 4
• Continuous infusion: 7-10 mcg/kg/min starting at T2 reappearance 4

Special Populations

Elderly Patients (≥65 years)

Use standard RSI doses (1.0 mg/kg) without reduction 7, 8

• Onset time is slightly prolonged but still adequate for RSI 7
• Duration of action is extended (median 46-94 minutes depending on dose) 4
• Rocuronium 0.9 mg/kg provides shorter onset time (108 seconds) vs 0.3 mg/kg (228 seconds) 8
• Do NOT reduce initial dose despite prolonged duration 9, 4

Hepatic Impairment

Use standard initial dose (0.6-1.2 mg/kg) but expect prolonged duration 3, 4

• Clinical duration is approximately 1.5 times longer than in patients with normal hepatic function 3, 4
• Rocuronium undergoes biliary excretion (up to 50% of dose) 3
• Reduce maintenance doses or infusion rates due to decreased clearance 3
• Consider using atracurium or cisatracurium as alternatives, as they undergo organ-independent elimination 9

Renal Failure

Use standard initial dose without adjustment 9, 4

• Onset time remains unchanged 9, 4
• Duration may be similar or slightly prolonged with greater individual variation 4
• Reduce maintenance requirements due to decreased clearance 3
• Sugammadex can be used at usual doses despite renal impairment 9

Obese Patients

Dose based on actual body weight (ABW), not ideal body weight 4

• Dosing by ABW provides superior intubating conditions 4
• Dosing by ideal body weight results in longer onset time and shorter duration 4
• Pharmacodynamics are not different between obese and non-obese patients when dosed by ABW 4

Critical Safety Considerations

Post-Intubation Sedation

The prolonged duration of rocuronium (30-60 minutes) creates significant risk for awareness with paralysis if sedation is inadequate 10

• Initiate continuous sedation within 12-14 minutes of rocuronium administration 10
• Propofol 20 mcg/kg/min or equivalent sedation should be started immediately after intubation 10
• The risk of awareness is higher with rocuronium than succinylcholine due to duration mismatch 2

Contraindications Favoring Rocuronium Over Succinylcholine

Use rocuronium when succinylcholine is contraindicated 11:

• Malignant hyperthermia history
• Severe burns/crush injury (>24-48 hours old)
• Spinal cord injury
• Neuromuscular disease or myopathy
• Risk of hyperkalemia

Inhalational Anesthetic Interactions

Reduce infusion rates by 30-50% when using enflurane or isoflurane 4

• Potentiation occurs at 45-60 minutes after intubating dose 4
• Effect is minimal if rocuronium given before volatile agent administration 4

Practical Algorithm for RSI Dosing

1. Standard adult RSI: 1.0-1.2 mg/kg IV (based on ABW if obese)
2. Pediatric RSI: 1.0-1.2 mg/kg IV (though FDA does not recommend for pediatric RSI)
3. Elderly (≥65 years): 1.0 mg/kg IV (no dose reduction)
4. Hepatic/renal impairment: Standard initial dose, reduce maintenance
5. Ensure sugammadex availability before administration
6. Initiate continuous sedation immediately post-intubation

The most common pitfall is underdosing rocuronium at 0.6 mg/kg for true RSI, which compromises first-pass success and intubating conditions 5. The second critical error is failing to provide adequate post-intubation sedation, risking awareness during the prolonged paralysis 10.